novel coronavirus pneumonia (NCP)
Conditions
Interventions
High dose group:High-dose NK cells (>5x10^9)and mesenchymal stem cells(>5x10^9),Intravenous infusion once every two days for a total of five times
Conventional dose group:Conventional dose NK cells (>3x10^9)and mesenchymal stem cells(>3x10^9),Intravenous infusion once every two days for a total of three times
Preventive dose group:Preventive dose NK cells (>3x10^9)and mesenchymal stem cells(>3x10^9),Intravenous infusion once every week for a total of one time
Sponsors
Guangzhou reborn health management consultation co., LTD
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients with confirmed new coronavirus-infected pneumonia; 2. Voluntarily sign written informed consent.
Exclusion criteria
Exclusion criteria: 1. Extremely ill patients with shock, acute respiratory distress syndrome, and multiple organ failure; 2. Pregnant or lactating women; 3. In the opinion of the investigator, previous or present illnesses may affect patients' participation in the trial or influence the outcome of the study, including: malignant disease, autoimmune disease, liver and kidney disease, blood disease, neurological disease, and endocrine Disease; currently suffering from diseases that seriously affect the immune system, such as: human immunodeficiency virus (HIV) infection, or the blood system, or splenectomy, organ transplantation, etc .; 4. The investigator believes that the patient has other conditions that are not suitable for enrollment.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Time and rate of coronavirus become negative;Clearance rate and time of main symptoms (fever, fatigue, cough);Exacerbation (transfer to RICU) time;Routine blood test;Biochemical Indicators;Immune indices; | — |
Primary
| Measure | Time frame |
|---|---|
| Time to disease recovery; | — |
Contacts
Public ContactChao Xu
Guangzhou reborn health management consultation co., LTD
Outcome results
None listed